2,2-bis(bromomethyl)-1,3-propanediol has been researched along with Escherichia coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, W; Huang, H; Zhao, G | 1 |
| Olusanya, O; Olutiola, PO | 1 |
2 other study(ies) available for 2,2-bis(bromomethyl)-1,3-propanediol and Escherichia coli Infections
| Article | Year |
|---|---|
Portable and quantitative point-of-care monitoring of Escherichia coli O157:H7 using a personal glucose meter based on immunochromatographic assay.
Topics: Animals; Antibodies, Immobilized; beta-Fructofuranosidase; Biosensing Techniques; Blood Glucose Self-Monitoring; Chromatography, Affinity; Equipment Design; Escherichia coli Infections; Escherichia coli O157; Food Analysis; Food Contamination; Glucose; Humans; Milk; Point-of-Care Systems | 2018 |
The purification and characterization of intracellular invertase obtained from pathogenic Escherichia coli.
Topics: beta-Fructofuranosidase; Child, Preschool; Diarrhea; Escherichia coli; Escherichia coli Infections; Female; Glycoside Hydrolases; Humans; Hydrogen-Ion Concentration; Infant; Infant, Newborn; Intracellular Fluid; Male; Molecular Weight | 1994 |